This inventor holds 1 USPTO granted patent and 3 published patent applications and 1 EPO patent. Top assignee: Zhejiang Hisun Pharmaceutical Co., Ltd.. Active years: 2014.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2014
Title: Ying Chen - Innovator in Cholesterol-Reducing Compounds
Introduction
Ying Chen is a notable inventor based in Sichuan, China. He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds aimed at reducing cholesterol levels in the blood.
Latest Patents
Ying Chen holds a patent for "Azetidinone compounds and medical use thereof." This invention provides a method for preparing azetidinone compounds, which are designed to lower total cholesterol (TC) and low-density lipoprotein cholesterol (LDL-C) in plasma. The compounds can be utilized as medicaments for treating or preventing various diseases, including atherosclerosis, cardiac failure, and hypercholesterolemia. The preparation methods for these compounds and their intermediates are also detailed in the patent.
Career Highlights
Ying Chen is currently associated with Zhejiang Hisun Pharmaceutical Co., Ltd., where he continues to innovate in the pharmaceutical sector. His work focuses on developing effective treatments for cholesterol-related health issues.
Collaborations
Ying Chen has collaborated with notable colleagues, including Hua Bai and Xuyang Zhao, contributing to advancements in his field.
Conclusion
Ying Chen's innovative work in azetidinone compounds represents a significant step forward in the fight against cholesterol-related diseases. His contributions are vital for the development of effective medical treatments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile